Interestingly, Zaslavskaya et al. compared gal-3 levels in patients suffering from metabolic syndrome (MS) with coexisting paroxysmal/persistent AF or without arrhythmia to healthy controls. This evidence concerns the gene LGALS3 and myeloid sarcoma.